Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+38.4%
5Y CAGR+28.5%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+38.4%/yr
vs -7.5%/yr prior
5Y CAGR
+28.5%/yr
Recent acceleration
Acceleration
+45.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $329.32M | +60.7% |
| 2024 | $204.98M | -25.4% |
| 2023 | $274.75M | +121.2% |
| 2022 | $124.23M | +20.0% |
| 2021 | $103.56M | +10.2% |
| 2020 | $93.94M | +238.1% |
| 2019 | $27.78M | -83.6% |
| 2018 | $169.39M | +352.8% |
| 2017 | $-67.02M | +10.7% |
| 2016 | $-75.05M | - |